Recently developed mTOR kinase inhibitors effectively block the activities of both complexes, thereby more dramatically inhibiting protein synthesis, suppressing AKT activation and inducing G1 arrest or apoptosis in tumor cells as compared to rapamycin [8]. The gene discussed is AKT1; the disease is neoplasm.